Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
about
Human ASH1 expression in prostate cancer with neuroendocrine differentiationNeuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failureDistinct genetic alterations in small cell carcinoma from different anatomic sitesIonizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancerMatrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progressionRegulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells.The role of epithelial plasticity in prostate cancer dissemination and treatment resistanceIonizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsOrigin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway.Platinum-based chemotherapy for variant castrate-resistant prostate cancer.Modeling a lethal prostate cancer variant with small-cell carcinoma features.Small cell carcinoma of the prostate.Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review.Factors implicated in radiation therapy failure and radiosensitization of prostate cancer.Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism.Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate.Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity.
P2860
Q24319673-FA269097-59F2-4DB8-B2F1-3BB77093B370Q26859201-D94D56E9-CC3E-47C7-B6A3-3BD8F0E6FCD7Q27008242-6F29F4C5-C2CC-489B-ACC6-B573DABF325EQ30432236-D7BA4E3C-E1AB-4CED-9E35-FDCAA634743AQ33356928-629273EA-E7F7-4D4A-859C-02075C9579ECQ33650205-881E63B8-157C-4285-A94D-EBAF3C09182AQ33732496-13DB0A01-B98D-44DF-BF7F-1D9094C5B493Q33957249-B6652254-7BA0-4F5D-BC63-7122926CD7CEQ34505037-85275C8A-3856-4582-BBB6-04658DC1D017Q35380936-AAF4CD80-C82C-484B-9776-4083831F0002Q36143611-702768B8-0702-4D22-AB87-10006638C42AQ36782301-0689C177-6045-434D-A739-FB78A9090A4DQ36882764-1E6345C6-03CE-4646-A6A9-1469BDC8DC44Q36977870-E46BB56C-3FE4-46C5-8520-582F7CCB979CQ37582049-0F414A97-2493-4938-86C3-14D36FEFCD16Q38188869-E33B8727-1979-45DD-A033-EAC321E47697Q38209356-A93F74A1-8474-4A15-8AB2-A37C90B362ECQ38807901-6283F9D5-A0A5-4F6C-9C68-647AB65224D6Q39905772-0B6DE1C5-C51B-4454-8707-F66B6E0066A2Q42151444-E4C6E1E2-0830-45E6-993F-2842532B769CQ43010807-70E56D34-FE2D-465A-834D-B71D941F3E1C
P2860
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@ast
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@en
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@nl
type
label
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@ast
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@en
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@nl
prefLabel
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@ast
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@en
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@nl
P356
P1433
P1476
Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.
@en
P2093
P A di Sant'Agnese
P304
P356
10.1023/A:1012402909428
P478
12 Suppl 2
P577
2001-01-01T00:00:00Z